Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vaccination × CNS × Clear all

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 2 Tumor-Agnostic 1 Plasma cell 1 Other hematologic neoplasm 1 Gynecologic 1 Gastrointestinal 1 Classical hematology 1 CNS 1 Breast 1

Conditions

Interventions

Temozolomide 527 Radiotherapy 347 Bevacizumab 217 Magnetic Resonance Spectroscopy 191 Radiosurgery 146 Cyclophosphamide 146 Carboplatin 133 Etoposide 109 Radiation 106 Irinotecan 97 Vincristine 90 Cisplatin 81 Filgrastim 80 pembrolizumab 76 Specimen Handling 75 Nivolumab 72 Lomustine 72 Surgical Procedures, Operative 68 Topotecan 57 Melphalan 50 Carmustine 49 Radiotherapy, Intensity-Modulated 48 Granulocyte Colony-Stimulating Factor 45 Doxorubicin 45 sargramostim 44 Peripheral Blood Stem Cell Transplantation 43 Blood Specimen Collection 43 Chemotherapy, Adjuvant 42 Isotretinoin 41 Erlotinib Hydrochloride 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05356312 2024-03-01

Glioblastoma and Individualized Therapies

Zentrum fur Humangenetik Tuebingen

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡